Scroll Back to Top

Study number 8530-848

Healthy Overweight Adults, age 18-65

Dates

Jun 25 2024-Dec 19 2024

Location

Dallas, Texas

Age

18-65

Gender

Both

Compensation

$17,665

Group

D1

Study Details

The investigational drug in this research study is being developed for the treatment of obesity.

The purpose of this study are to look at:

  • How well the study drugs are tolerated and any side effects of the study drugs
  • The effect of the study drugs on body weight
  • How much of the study drug gets into the blood stream and how long it takes the body to get rid of it when given tirzepatide is an investigational drug that has been approved by the FDA for the treatment of type 2 diabetes mellitus and chronic weight management. The use of tirzepatide in this study is investigational.

 

Fortrea Dallas, TX is recruiting for:

-Healthy Overweight Men and Women, age 18-65

-Body Mass Index between 27-45

-Study involves multiple overnight stays & outpatient visits

-Compensation up to $17,665 may be provided for time and participation

-Refer a friend to receive $300 per qualified referral

Additional Details

Cohort B2:

Check-in: Jun 25

Check-out: Jun 30

Check-in: Jul 3

Check-out: Jul 4

Check-in: Jul 10

Check-out: Jul 11

Check-in: Jul 17

Check-out: Jul 18

Check-in: Jul 24

Check-out: Jul 25

Check-in: Jul 31

Check-out: Aug 1

Check-in: Aug 7

Check-out: Aug 8

Check-in: Aug 14

Check-out: Aug 15

Check-in: Aug 21

Check-out: Aug 22

Check-in:  Aug 28

Check-out: Aug 29

Check-in: Sep 4

Check-out: Sep 5

Check-in: Sep 11

Check-out: Sep 12

Check-in: Sep 18

Check-out: Sep 19

Check-in: Sep 25

Check-out: Sep 26

Check-in: Oct 2

Check-out: Oct 3

Check-in: Oct 9

Check-out: Oct 13

Outpatient Visits: Oct 24, Nov 7, 21, Dec 5, 19

 

BMI Calculator

Weight

Height

Feet Inches